Farnesyltransferase Inhibitors Reverse Taxane Resistance

The combination of farnesyltransferase inhibitors (FTIs) and taxanes has been shown to result in potent antiproliferative and antimitotic synergy. Recent phase I and II clinical trials have shown that this combination shows clinical activity in taxane-refractory or taxane-resistant cancer patients....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Marcus, Adam I., O’Brate, Aurora M., Buey, Ruben M., Zhou, Jun, Thomas, Shala, Khuri, Fadlo R., Andreu, Jose Manuel, Díaz, Fernando, Giannakakou, Paraskevi
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2006
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1861825/
https://ncbi.nlm.nih.gov/pubmed/16951201
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-06-0699
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge